Pharmacy Question for the Week of October 19, 2020
When we are revising a treatment plan for services related to infusion, how should we support the inclusion of new drugs?
Menu
Menu
When we are revising a treatment plan for services related to infusion, how should we support the inclusion of new drugs?
When billing for infusion services, would we need to validate the NCD on a claim for the drug vial?
How are no-cost drugs indicated for infusion services when following payer protocols?
Can we use hydration codes to report drug infusion?
How can payers help combat the opioid crisis?
What code would be reported for the injection of radiopharmaceuticals into the lumbar spine?
Do pharmacists fall within the regulatory definition of auxiliary personnel under the “incident to” regulations or is this changing for 2021?
Can you tell me more about the updates for drug codes under the Cosmetic Act in the 2021 proposed Medicare Physician Fee Schedule?
What are the challenges of the Promotion of Medication-Assisted Treatment (MAT) program?
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2025 MedLearn Publishing. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24